Kariya Pharmaceuticals
Pre-clinicalKariya Pharmaceuticals is a biotechnology company developing innovative disease modifying agents to treat neurodegenerative diseases such as Parkinson’s and Alzheimer’s Disease. Kariya is supported by funding from the Novo Nordisk Foundation’s Biolnnovation Institute and Innovation Fund Denmark.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.5M
About
Kariya Pharmaceuticals is a biotechnology company developing innovative disease modifying agents to treat neurodegenerative diseases such as Parkinson’s and Alzheimer’s Disease. Kariya is supported by funding from the Novo Nordisk Foundation’s Biolnnovation Institute and Innovation Fund Denmark.
Small Molecules
Funding History
1Total raised:$2.5M
Seed$2.5MJun 15, 2022